Michael Gold to Cardiomyopathies
This is a "connection" page, showing publications Michael Gold has written about Cardiomyopathies.
Connection Strength
1.424
-
Predicting cardiac resynchronization therapy outcomes: It is more than just left bundle branch block. Heart Rhythm. 2018 11; 15(11):1673-1674.
Score: 0.525
-
Biventricular pacemaker/defibrillators versus biventricular pacemakers in patients with non-ischemic cardiomyopathy. Card Electrophysiol Clin. 2015 Sep; 7(3):455-9.
Score: 0.428
-
Meta-analysis comparing outcomes of catheter ablation for ventricular arrhythmia in ischemic versus nonischemic cardiomyopathy. Pacing Clin Electrophysiol. 2021 01; 44(1):54-62.
Score: 0.156
-
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Heart Rhythm. 2014 Jul; 11(7):1271-303.
Score: 0.099
-
Newer Indications for ICD and CRT. Cardiol Clin. 2014 May; 32(2):181-90.
Score: 0.097
-
Cardiac sarcoidosis. Am Heart J. 2009 Jan; 157(1):9-21.
Score: 0.068
-
Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy. Am J Cardiol. 1995 Mar 01; 75(7):460-4.
Score: 0.026
-
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Circulation. 2014 Jul 01; 130(1):94-125.
Score: 0.025